Skip to main content

What You MUST Know As More Lymphoma Patients Are On The Road To CAR-T

Part 2 of 4 in a series on: The Evolving Role of CAR T-cell Therapy for R/R B-cell Lymphomas: Improving Access and Outcomes

Click Here to Participate 

CE Activity Release Date: March 11, 2022
CE Activity Expiration Date: April 8, 2023 
Time to Complete Activity: 60 minute
1.0 CME/CE Credit/Contact Hour for physicians, registered nurses, pharmacists, social workers and case managers

 

Target Audience

This CE activity is intended for community-based hematologists-oncologists, fellows, NPs, PAs, nurses, pharmacists, navigators, social workers, and case managers engaged in the care of patients with R/R B-cell lymphomas.

 

Description

What you MUST know as more lymphoma patients are on the road to CAR-T, episode 2 of the 4-part educational initiative The Evolving Role of CAR T-cell Therapy for R/R B-cell Lymphomas: Improving Access and Outcomes, is designed for community-based oncology clinicians. Through interactive discussion among cellular therapy experts and a community-based oncologist, this activity provides practical information regarding management of acute, delayed, and late toxicities of CAR-T therapy and what your patients and their caregivers need to know before, during, and after treatment.  Videos, animations, and key learning points address clinical challenges with interprofessional perspectives to foster meaningful change. 

 

Educational Objectives

After completing this CE activity, the participant should be better able to:

  • Monitor for and manage cytokine release syndrome and hemophagocytic lymphohistiocytosis (HLH)
  • Monitor for and manage neurologic toxicities
  • Educate patients on what to expect before, during, and after treatment 

 

Faculty/Hosts

Sergio A. Giralt, MD, FACP
Melvin Berlin Family Chair in Myeloma Research
Professor of Medicine
Weill Cornell Medical College
Deputy Head, Division of Hematologic Malignancies
Attending Physician, Adult BMT Service 
Memorial Sloan Kettering Cancer Center
New York, NY

Sanjay K. Juneja, MD
Hematology, Medical Oncology
Chief of Oncology Line            
Baton Rouge General Hospital
Mary Bird Perkins Cancer Center
Baton Rouge, LA

Rayne H. Rouce, MD, BS
Associate Professor
Department of Pediatrics
Texas Children’s Cancer Center for Cell and Gene Therapy
Baylor College of Medicine
Houston, TX

Guests

Rebecca A. Gardner, MD
Associate Professor, Department of Pediatrics
University of Washington
Pediatric Oncologist, Seattle Children’s Hospital
Seattle, WA

Theresa Elko, MPAS, PA-C
Clinical Research Physician Assistant
Memorial Sloan Kettering Cancer Center
New York, NY
 

Educational Partner Statement

This activity is developed with our educational partner, Medical Learning Institute, Inc.

In support of improving patient care, this activity has been planned and implemented by Medical Learning Institute, Inc. and The Leukemia & Lymphoma Society.   Medical Learning Institute, Inc. is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

This activity is certified for 1.0 credit/contact hour for physicians, registered nurses, pharmacists, physician assistants, social workers and case managers.

 

Support Statement

This activity is supported by an independent educational grant from Bristol Myers Squibb.

 

Method of Participation

There are no fees for participating in or receiving credit for this CE activity. In order to receive credit, learners must participate in the entire CE activity, complete the post-test and activity evaluation form and your certificate of credit will be generated. 
 

 

For questions, concerns, or for assistance for people with disabilities or grievances, please contact us at ProfEducation@LLS.org